CORT
$114.03-1.05%
as of close, Oct 1, 2026
☾ AH $114.03 -1.05%
Corcept Therapeutics IncorporatedStock · Health CareNasdaq Composite 0.02%Russell 1000 0.01%Russell 3000 0.01%US Stock Market 0.01%
CORT financial statements
The full income statement, balance sheet, and cash-flow statement for Corcept Therapeutics Incorporated (CORT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 104.5M2024-09 104.8M2024-12 105.5M2025-03 106.0M2025-06 105.4M2025-09 105.2M2025-12 106.4M2026-03 107.4M2026-06 108.1M+3.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 761M+12.8% | 675M+39.9% | 482M+20.0% | 402M+9.8% | 366M+3.4% | |
| Cost of revenue | 13.0M+19.3% | 10.9M+67.9% | 6.48M+20.4% | 5.38M+2.0% | 5.28M-5.4% | |
| Research & development | 255M+3.2% | 247M+33.9% | 184M+40.7% | 131M+15.0% | 114M-0.8% | |
| Selling, general & administrative | 449M+60.1% | 280M+52.1% | 184M+20.6% | 153M+24.9% | 122M+16.2% | |
| Amortization of intangibles | — | — | 465K-2.5% | 477K+16.6% | 409K | |
| Operating income | 44.8M-67.3% | 137M+27.7% | 107M-4.8% | 113M-9.5% | 124M-2.9% | |
| Other non-operating income | 21.7M-11.7% | 24.5M+42.1% | 17.3M+385.7% | 3.56M+572.4% | 529K | |
| Pre-tax income | 66.5M-58.8% | 161M+29.7% | 125M+7.2% | 116M-7.1% | 125M-5.0% | |
| Income tax | -33.2M-263.6% | 20.3M+10.1% | 18.4M+24.7% | 14.8M+18.2% | 12.5M-51.2% | |
| 99.7M-29.4% | 141M+33.0% | 106M+4.7% | 101M-9.9% | 113M+6.1% | ||
| Net income to common | 98.2M-29.7% | 140M+32.5% | 105M+4.2% | 101M-10.0% | 113M+6.1% | |
| $0.82-33.3% | $1.23+30.9% | $0.94+8.0% | $0.87-2.2% | $0.89+4.7% | ||
| EPS (basic) | $0.95-29.6% | $1.35+32.4% | $1.02+7.4% | $0.95-2.1% | $0.97+5.4% | |
| Weighted-avg shares (basic) | 104M+0.6% | 103M-0.3% | 104M-3.0% | 107M-7.7% | 116M+0.2% | |
| Weighted-avg shares (diluted) | 120M+5.7% | 113M+1.6% | 112M-3.6% | 116M-7.9% | 126M+1.4% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 485M+2.9% | 472M+2.8% | 459M-8.1% | 499M+87.4% | 266M-44.3% | ||
| Cash & equivalents | 120M-5.6% | 128M-5.8% | 136M+104.4% | 66.3M-14.5% | 77.6M+1.9% | |
| Short-term investments | 252M-1.6% | 256M+9.9% | 233M-36.3% | 365M+150.4% | 146M-60.0% | |
| Accounts receivable | 59.8M+10.8% | 54.0M+31.3% | 41.1M+32.4% | 31.1M+12.4% | 27.6M+5.4% | |
| Inventory | 12.9M+3.7% | 12.4M+60.6% | 7.73M+26.7% | 6.10M+22.3% | 4.99M+1.6% | |
| Prepaid expenses | 40.7M+85.8% | 21.9M-20.6% | 27.6M+67.8% | 16.4M+59.2% | 10.3M+54.0% | |
| Other current assets | 7.10M+16.8% | 6.08M+3.3% | 5.88M | — | — | |
| 837M-0.5% | 841M+35.2% | 622M+6.5% | 583M+37.7% | 424M-25.9% | ||
| Property, plant & equipment | 1.89M-29.7% | 2.69M+1279.0% | 195K-69.2% | 633K-36.8% | 1.00M-40.2% | |
| Operating lease right-of-use | 4.58M-13.9% | 5.32M+4336.7% | 120K-89.5% | 1.14M+122.4% | 514K-79.5% | |
| Long-term investments | 160M-27.1% | 220M+284.5% | 57.2M+1055.8% | 4.95M-95.6% | 112M+210.2% | |
| Deferred tax assets | 168M+28.5% | 131M+44.5% | 90.6M+47.4% | 61.5M+123.9% | 27.5M-13.1% | |
| Other non-current assets | 5.15M-22.0% | 6.61M+1.1% | 6.54M+29.3% | 5.06M+64.1% | 3.08M-38.3% | |
| 166M+18.0% | 141M+34.7% | 105M+44.2% | 72.5M+52.5% | 47.5M+0.1% | ||
| Accounts payable | 40.4M+163.0% | 15.4M-11.6% | 17.4M+45.3% | 12.0M+73.4% | 6.91M-34.5% | |
| Accrued liabilities | 90.6M-0.1% | 90.7M+75.7% | 51.6M+67.6% | 30.8M+11.3% | 27.7M+30.6% | |
| Current lease liability | 1.08M+30.8% | 829K+449.0% | 151K-86.8% | 1.14M+117.3% | 526K-74.3% | |
| 189M+17.3% | 161M+40.2% | 115M+40.7% | 81.6M+70.2% | 48.0M-0.9% | ||
| Non-current lease liability | 5.02M-17.8% | 6.11M | 0.00 | — | 0.00-100.0% | |
| Operating lease liability (total) | 6.11M-12.0% | 6.94M+4493.4% | 151K-86.8% | 1.14M+117.3% | 526K-79.4% | |
| 648M-4.7% | 680M+34.1% | 507M+1.0% | 502M+33.5% | 376M-28.2% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 140K+2.9% | 136K+2.3% | 133K+1.5% | 131K+3.1% | 127K+4.1% | |
| Additional paid-in capital | 969M+16.4% | 832M+12.7% | 739M+11.5% | 662M+12.0% | 591M+14.6% | |
| Retained earnings | 643M+18.3% | 544M+35.1% | 403M+35.8% | 296M+52.0% | 195M+136.5% | |
| Treasury stock | 967M+38.8% | 696M+9.6% | 635M+39.2% | 456M+11.1% | 410M+441.5% | |
| Accumulated other comprehensive income | 2.26M+1143.3% | -217K-135.6% | 609K+170.1% | -869K-282.8% | -227K-154.7% | |
| Total liabilities & equity | 837M-0.5% | 841M+35.2% | 622M+6.5% | 583M+37.7% | 424M-25.9% | |
| Common shares issued | 143M+3.5% | 138M+2.5% | 134M+2.6% | 131M+2.9% | 127M+3.8% | |
| Common shares outstanding | 106M+0.8% | 105M+1.7% | 103M-4.1% | 108M+1.8% | 106M-9.2% | |
| Shares outstanding (cover) | 106M+0.8% | 106M+1.9% | 104M-4.1% | 108M+1.8% | 106M-9.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 142M-28.4% | 198M+56.5% | 127M+5.3% | 120M-28.3% | 168M+10.5% | ||
| Depreciation & amortization | 1.15M+44.5% | 795K-23.7% | 1.04M-17.2% | 1.26M+17.4% | 1.07M+104.2% | |
| Intangible amortization | — | — | 465K-2.5% | 477K+16.6% | 409K | |
| Share-based compensation | 84.5M+37.7% | 61.4M+25.4% | 48.9M+15.3% | 42.4M-1.1% | 42.9M+28.0% | |
| Deferred income taxes | -37.5M+6.6% | -40.2M-36.3% | -29.5M+13.0% | -33.9M-880.1% | 4.35M-69.2% | |
| Change in receivables | 5.81M-54.8% | 12.9M+27.7% | 10.1M+193.3% | 3.43M+140.5% | 1.43M-77.2% | |
| Change in inventory | 7.48M+2552.8% | -305K+75.9% | -1.26M-5.5% | -1.20M+65.2% | -3.44M-198.0% | |
| Change in payables | 25.1M+1341.0% | -2.02M-137.3% | 5.42M+13.9% | 4.76M+232.2% | -3.60M-213.8% | |
| 69.8M+139.3% | -178M-295.4% | 90.9M+179.5% | -114M-184.0% | 136M+214.1% | ||
| Capital expenditure | 211K-90.3% | 2.17M+1462.6% | 139K-66.3% | 413K-11.9% | 469K-62.1% | |
| Free cash flow | 142M-27.7% | 196M+55.0% | 127M+5.5% | 120M-28.4% | 167M+11.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales/maturities of investments | — | — | 420M+74.1% | 241M-39.6% | 399M+32.1% | |
| -220M-677.3% | -28.3M+80.9% | -149M-760.5% | -17.3M+94.3% | -303M-2577.4% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 173M+1003.9% | 15.7M | 0.00 | 0.00 | 0.00-100.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 1.44M+732.5% | -228K-163.7% | 358K | — | — | |
| Net change in cash | -7.17M+9.1% | -7.89M-111.4% | 69.2M+713.2% | -11.3M-891.0% | 1.43M-96.8% | |
| Income taxes paid | 13.0M-78.5% | 60.3M+26.6% | 47.6M+19.8% | 39.7M+336.6% | 9.10M-16.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 3.70B-30.4% | 5.32B+58.8% | 3.35B+53.1% | 2.19B+4.2% | 2.10B-31.6% | |
| P/E | 37.1×-1.3% | 37.6×+2.8% | 36.6×+95.8% | 18.7×+0.3% | 18.6×-35.6% | |
| P/S | 4.9×-38.3% | 7.9×+5.9% | 7.4×+35.3% | 5.5×-4.1% | 5.7×-33.9% | |
| P/B | 5.7×-27.0% | 7.8×+7.9% | 7.3×+57.0% | 4.6×-17.3% | 5.6×-4.8% | |
| P/FCF | 26.1×-3.7% | 27.1×+25.0% | 21.7×+34.8% | 16.1×+28.4% | 12.5×-38.5% | |
| Earnings yield | 2.7%+1.3% | 2.7%-2.7% | 2.7%-48.9% | 5.3%-0.3% | 5.4%+55.2% | |
| FCF yield | 3.8%+3.8% | 3.7%-20.0% | 4.6%-25.8% | 6.2%-22.1% | 8.0%+62.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: CORT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CORT filings on SEC EDGAR → Not investment advice.